Udo Losehand, head of Global Technical Developers at Roquette looks at the benefits precision dispensing technology can offer biopharma manufacturers thanks to its versatility and customisability.
Kevin Seaver, general manager, Bioprocess Automation and Digital, Bioprocess Program at Cytiva explores the digital age of bioprocessing and how manufacturers are benefitting from advancements in the sector.
Mario Pereira, field application scientist for bioproduction at Horizon Discovery, a PerkinElmer company, comments on the advantages of using CHO cells for biomanufacturing and explains how gene editing technologies are increasing their utility.
Ben Wylie, senior product manager at ChargePoint Technology, argues that single-use (SU) technology is central to helping biotechs optimise efficiency in order to meet fast-growing demand for biologic treatments.
Sahana Mollah, senior manager, Global BioPharma Collaboration & CE Tech Marketing at SCIEX looks at how antibody variants are helping researchers develop new medicines.
Mark A. Sitcoske, founder & CEO of High Purity New England (HPNE) explains the benefits of using single-use systems to scale up from development to full-scale production in biomanufacturing facilities.
Danny Galbraith - head of New Services and Technology Management at Merck KGaA, Darmstadt, Germany, explores the innovation bringing RNA Therapeutics to the clinic.
This In Conversation feature sees Dr Thomas Kofoed co-founder of Alphalyse speaking to Mani Krishnan, VP/GM of SCIEX about the work the company is doing to help improve biologic drug development.
Ben Wylie, senior product manager at ChargePoint Technology explains how single use technologies can help pharmaceutical manufacturers during bioprocessing.
Professor Ian Marison (BCC) and Dr Peter Levison (Pall Corporation) speak to EPM about the most pressing challenges facing the biopharma industry and what needs to be done to tackle the growing skills shortage.
